4-(((2R,3R)-1,3-Dihydroxybutan-2-yl)amino)-6-phenylpyrrolo[1,2-b]pyridazine-3-carboxamide

Catalog No. :
ACHPFM057
CAS No. :
1400876-94-9
Molecular Formula :
C18H20N4O3
Molecular Weight :
340.38

IUPAC Name:4-(((2R,3R)-1,3-dihydroxybutan-2-yl)amino)-6-phenylpyrrolo[1,2-b]pyridazine-3-carboxamide

4-(((2R,3R)-1,3-Dihydroxybutan-2-yl)amino)-6-phenylpyrrolo[1,2-b]pyridazine-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$196.00Login to see priceInquiryInquiry
2mg98%$281.00Login to see priceInquiryInquiry
5mg98%$485.00Login to see priceInquiryInquiry
10mg98%$694.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(((2R,3R)-1,3-Dihydroxybutan-2-yl)amino)-6-phenylpyrrolo[1,2-b]pyridazine-3-carboxamide
IUPAC Name4-(((2R,3R)-1,3-dihydroxybutan-2-yl)amino)-6-phenylpyrrolo[1,2-b]pyridazine-3-carboxamide
Molecular FormulaC18H20N4O3
Molecular Weight340.38
SMILESO=C(N)C(C=NN1C=C(C=C21)C3=CC=CC=C3)=C2N[C@@H]([C@@H](C)O)CO
InChI KeyPRWQQLFMBINSAW-IAQYHMDHSA-N
SynonymJAK-IN-3 (COMPOUND 22);JAK-IN-3;JAKIN3,JAK IN 3;Pyrrolo[1,2-b]pyridazine-3-carboxamide, 4-[[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]amino]-6-phenyl-
CAS No.1400876-94-9

Synthetic Route by SureRoute

1. ACHPFM057 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACHPFM057 route product structure diagram
    ACHPFM0571400876-94-9
Inquiry

2. ACHPFM057 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRFWN071 route compound structure diagram
    ACRFWN0713228-51-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHPFM057 route product structure diagram
    ACHPFM0571400876-94-9
Inquiry

Comments (0)